283 related articles for article (PubMed ID: 34944574)
1. Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort.
Pinto PC; Rönnau C; Burchardt M; Wolff I
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944574
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
Nasri H
Cell J; 2014; 15(4):378-80. PubMed ID: 24381864
[TBL] [Abstract][Full Text] [Related]
3. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.
Legrand M; Mik EG; Johannes T; Payen D; Ince C
Mol Med; 2008; 14(7-8):502-16. PubMed ID: 18488066
[TBL] [Abstract][Full Text] [Related]
4. The smell of renal protection against chronic kidney disease: Hydrogen sulfide offers a potential stinky remedy.
Dugbartey GJ
Pharmacol Rep; 2018 Apr; 70(2):196-205. PubMed ID: 29471067
[TBL] [Abstract][Full Text] [Related]
5. The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
Hesp AC; Schaub JA; Prasad PV; Vallon V; Laverman GD; Bjornstad P; van Raalte DH
Kidney Int; 2020 Sep; 98(3):579-589. PubMed ID: 32739206
[TBL] [Abstract][Full Text] [Related]
6. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease.
Heyman SN; Khamaisi M; Rosen S; Rosenberger C
Am J Nephrol; 2008; 28(6):998-1006. PubMed ID: 18635927
[TBL] [Abstract][Full Text] [Related]
7. Role of hypoxia in the pathogenesis of renal disease.
Eckardt KU; Bernhardt WM; Weidemann A; Warnecke C; Rosenberger C; Wiesener MS; Willam C
Kidney Int Suppl; 2005 Dec; (99):S46-51. PubMed ID: 16336576
[TBL] [Abstract][Full Text] [Related]
8. Perspective in chronic kidney disease: targeting hypoxia-inducible factor (HIF) as potential therapeutic approach.
Deshmukh AB; Patel JK; Prajapati AR; Shah S
Ren Fail; 2012; 34(4):521-32. PubMed ID: 22264075
[TBL] [Abstract][Full Text] [Related]
9. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
Nangaku M
J Am Soc Nephrol; 2006 Jan; 17(1):17-25. PubMed ID: 16291837
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease.
Thomas JL; Pham H; Li Y; Hall E; Perkins GA; Ali SS; Patel HH; Singh P
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F282-F290. PubMed ID: 28331062
[TBL] [Abstract][Full Text] [Related]
11. Signalling pathways involved in hypoxia-induced renal fibrosis.
Liu M; Ning X; Li R; Yang Z; Yang X; Sun S; Qian Q
J Cell Mol Med; 2017 Jul; 21(7):1248-1259. PubMed ID: 28097825
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and the HIF system in kidney disease.
Nangaku M; Eckardt KU
J Mol Med (Berl); 2007 Dec; 85(12):1325-30. PubMed ID: 18026918
[TBL] [Abstract][Full Text] [Related]
13. Role of Hypoxia in Renal Failure Caused by Nephrotoxins and Hypertonic Solutions.
Heyman SN; Khamaisi M; Zorbavel D; Rosen S; Abassi Z
Semin Nephrol; 2019 Nov; 39(6):530-542. PubMed ID: 31836036
[TBL] [Abstract][Full Text] [Related]
14. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics.
Fine LG; Norman JT
Kidney Int; 2008 Oct; 74(7):867-72. PubMed ID: 18633339
[TBL] [Abstract][Full Text] [Related]
15. Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction.
Palm F; Nordquist L
Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):474-80. PubMed ID: 21545630
[TBL] [Abstract][Full Text] [Related]
16. Expanding roles of the hypoxia-response network in chronic kidney disease.
Tanaka T
Clin Exp Nephrol; 2016 Dec; 20(6):835-844. PubMed ID: 26857707
[TBL] [Abstract][Full Text] [Related]
17. Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis.
Rayego-Mateos S; Campillo S; Rodrigues-Diez RR; Tejera-Muñoz A; Marquez-Exposito L; Goldschmeding R; Rodríguez-Puyol D; Calleros L; Ruiz-Ortega M
Clin Sci (Lond); 2021 Aug; 135(16):1999-2029. PubMed ID: 34427291
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia causes important changes of extracellular matrix biomarkers and ADAMTS proteinases in the adriamycin-induced renal fibrosis model.
Armutcu F; Demircan K; Yildirim U; Namuslu M; Yagmurca M; Celik HT
Nephrology (Carlton); 2019 Aug; 24(8):863-875. PubMed ID: 30719800
[TBL] [Abstract][Full Text] [Related]
19. The oxygen cascade in patients treated with hemodialysis and native high-altitude dwellers: lessons from extreme physiology to benefit patients with end-stage renal disease.
Kooman JP; Stenvinkel P; Shiels PG; Feelisch M; Canaud B; Kotanko P
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F249-F261. PubMed ID: 33356957
[TBL] [Abstract][Full Text] [Related]
20. Twist is a new prognostic marker for renal survival in patients with chronic kidney disease.
Sun S; Du R; Xia L; Sun W; Zhai Y; Yu Y; Zhao A; Huang C; Ning X; Wang H
Am J Nephrol; 2012; 35(2):141-51. PubMed ID: 22248584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
